Finding may help in screening women with endometriosis for cancer risk
Mutations in a gene called ARID1A may be responsible for some cases of ovarian cancer, two studies released September 8 show. The findings establish that the gene normally has a tumor-suppressing role, researchers report in Science and the New England Journal of Medicine.
The findings also improve the outlook for treating and screening ovarian clear-cell carcinoma, which comprises up to 10 percent of ovarian cancers, says David Huntsman, a pathologist and cancer geneticist at the University of British Columbia in Vancouver, Canada.
“Ovarian cancer management was a bit of a quagmire until recently, largely because people were treating it as a single disease,” he says. “It’s not.”
Ovarian cancer is stealthy. Only one in five cases is caught before the cancer has spread beyond the ovaries. Ovarian clear-cell carcinoma is a particularly aggressive form that responds poorly to treatment and can recur.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.